参考文献/References:
[1]XU J,ZOU M H.Molecular insights and therapeutic targets for diabetic endothelial dysfunction[J].Circulation,2009,120(13):1266-1286.
[2]张洪钧,加倩,乔彤彤,等.基于五运六气理论调整体质治疗高脂血症临床研究[J].国际中医中药杂志,2020,42(1):2025:20-25.
[3]MOGHADDAM M G,AHMAD F H,SAMZADEH-KERMANI A.Biological activity of betulinic acid:A review[J].Pharmacology & Pharmacy,2012,3(2):119-123.
[4]徐先祥,秦思,李琼.桦木酸抗炎作用与机制[J].中国现代应用药学,2014,31(10):1284-1287.
[5]GHEORGHEOSU D,DUICU O,DEHELEAN C,et al.Betulinic acid as a potent and complex antitumor phytochemical:A minireview[J].Anti-cancer Agents in Medicinal Chemistry,2014,14(7):936.
[6]CSUK R.Betulinic acid and its derivatives:A patent review (2008-2013)[J].Expert Opinion on Therapeutic Patents,2014,24(8):913-923.
[7]JONNALAGADDA S C,CORSELLO M A,SLEET C E.Betulin-betulinic acid natural product based analogs as anti-cancer agents[J].Anti-cancer Agents in Medicinal Chemistry,2013,13(10):1477.
[8]OYEBANJI B O,SABA A B,ORIDUPA O A.Studies on the anti-inflammatory,analgesic and antipyrexic activities of betulinic acid derived from Tetracera potatoria[J].Afr J Tradit Complement Altern Med,2014,11(1):30-33.
[9]李佩云,苑功名,徐媛,等.基于炎性痛模型初探针刺对cGAS/STING信号通路的双向调节效应[J].陕西中医,2025,46(6):746-750.
[10]羊羡,席建元,谢汶芳,等.银屑平丸调节cGAS-STING信号通路对银屑病小鼠的保护作用[J].陕西中医,2024,45(11):1466-1470.
[11]HE W,MU X,WU X,et al.The cGAS-STING pathway:A therapeutic target in diabetes and its complications[J].Burns Trauma,2024,12(2):tkad050.
[12]刘江金,张健,王承飞,等.cGAS-STING信号通路在不同程度冠状动脉粥样硬化病变下的表达研究[J].重庆医科大学学报,2025,50(8):1109-1114.
[13]林秋玉,何思懿,刘玲娟,等.cGAS/STING/IFN-Ⅰ信号通路介导内皮祖细胞对系统性红斑狼疮相关性动脉粥样硬化的保护作用[J].中国医师杂志,2024,26(12):1766-1772.
[14]ODURO P K,ZHENG X,WEI J,et al.The cGAS-STING signaling in cardiovascular and metabolic diseases:Future novel target option for pharmacotherapy[J].Acta Pharm Sin B,2022,12(1):50-75.
[15]符杰,邓红艳,李玉凯,等.丹参酮ⅡA抑制糖尿病动脉粥样硬化大鼠动脉平滑肌细胞凋亡及机制[J].中南医学科学杂志,2023,51(1):37-40.
[16]LEMOS H,MOHAMED E,HUANG L,et al.Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice[J].Immunology,2019,158(4):353-361.
[17]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(上)[J].中国实用内科杂志,2021,41(8):668-695.
[18]POZNYAK A,GRECHKO A V,POGGIO P,et al.The diabetes mellitus-atherosclerosis connection:The role of lipid and glucose metabolism and chronic inflammation[J].International Journal of Molecular Sciences,2020,21(5):1835.
[19]孟庆欣,魏英民,隆献.糖尿病引发动脉粥样硬化机制研究进展[J].糖尿病新世界,2024,27(11):195-198.
[20]许丹丹.红花黄色素对2型糖尿病合并动脉粥样硬化者氧化应激及炎症反应的影响[D].济南:山东大学,2017.
[21]王悦,张强,李美秋,等.桦木酸提取、合成及药理作用的研究进展[J].生物学通报,2020,55(11):1-5.
[22]KIM S J,QUAN H Y,JEONG K J,et al.Beneficial effect of betulinic acid on hyperglycemia via suppression of hepatic glucose production[J].J Agric Food Chem,2014,62(2):434-442.
[23]SPILLMANN F,MITEVA K,PIESKE B,et al.High-density lipoproteins reduce endothelial-to-mesenchymal transition[J].Arterioscler Thromb Vasc Biol,2015,35(8):1774-1777.
[24]诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.
[25]王晶,刘易婷,刘哲.达格列净和维格列汀对糖尿病合并冠心病老年患者血糖、血管内皮功能及心功能的影响[J].陕西医学杂志,2022,51(12):1581-1584.
[26]RAMZY D,RAO V,TUMIATI L C,et al.Elevated endothelin-1 levelsimpair nitric oxide homeostasis through a PKC-dependent pathway[J].Circulation,2006,114(1 Suppl):1319.
[27]李自成,毛爱琴,石萧明,等.蒙花苷靶向内凝集蛋白1改善糖尿病血管内皮功能障碍的作用及机制[J].食品科学,2025,46(8):170-177.
[28]ZHANG X,BAI X C,CHEN Z J.Structures and mechanismsin the cGAS-STING innate immunity pathway[J].J Immunity,2020,53(1),43-53.
[29]WANG Y,LUO J,ALU A,et al.cGAS-STING pathway in cancer biotherapy[J].Mol Cancer,2020,19(1):136.
[30]CHEN C,XU P.Cellular functions of cGAS-STING signaling[J].Trends Cell Biol,2023,33(8):630-648.
[31]丁慧晴,周玉莹,印旨意,等.cGAS-STING通路在代谢性心血管疾病中的作用[J].中南大学学报(医学版),2023,48(7):1086-1097.